Idarubicin hydrochloride
Cat. No.：YN250705
| 产品名称: | Idarubicin hydrochloride |
| CAS No.: | 57852-57-0 |
| Chemical Name: | (7S,9S)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione, monohydrochloride |
| Synonyms: | 盐酸伊达比星; 4-Demethoxydaunorubicin hydrochloride |
| 分子量: | 533.95 |
| 分子式: | C₂₆H₂₈ClNO₉ |
| SMILES: | OC(C(C(C1=CC=CC=C21)=O)=C3C2=O)=C4[C@H](C[C@@](C(C)=O)(O)CC4=C3O)O[C@@](O[C@@H](C)[C@H]5O)([H])C[C@@H]5N.Cl |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Idarubicin hydrochloride 是一种蒽环类抗白血病药物。 它抑制拓扑异构酶 II，干扰 DNA 复制和 RNA 转录。Idarubicin hydrochloride 还抑制细菌和酵母菌的生长。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Arcamone, F.Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lectureCancer Res.45(12 Pt 1),5995-5999(1985)
Dautant, A., d'Estaintot, B.L., Gallois, B., et al.A trigonal form of the idarubicin:d(CGATCG) complex; crystal and molecular structure at 2.0 Å resolutionNucleic Acids Res.23(10),1710-1716(1995)
Binaschi, M., Farinosi, R., Austin, C.A., et al.Human DNA topoisomerase IIα-dependent DNA cleavage and yeast cell killing by anthracycline analoguesCancer Res.58,1886-1892(1998)
Tallman, M.S., Gilliland, D.G., and Rowe, J.M.Drug therapy for acute myeloid leukemiaBlood106(4),1154-1163(2005)
Wang, Z.Y., and Chen, Z.Acute promyelocytic leukemia: From highly fatal to highly curableBlood111(5),2505-2515(2008)
